Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R MEYER

Showing results (681-690 of 2,204) with videos related to

Pageof 221
Sort By:
Analytica Chimica Acta|April 15, 2014
Methylenedioxy designer drugs: mass spectrometric characterization of their glutathione conjugates by means of liquid chromatography-high-resolution mass spectrometry/mass spectrometry and studies on their glutathionyl transferase inhibition potencyMarkus R Meyer, Lilian H J Richter, Hans H Maurer
IEEE Transactions on Medical Imaging|January 1, 1993
Polynomial modeling and reduction of RF body coil spatial inhomogeneity in MRIM Tincher, C R Meyer, R Gupta, et al.
Analytical and Bioanalytical Chemistry|January 24, 2014
Studies on the metabolism and the detectability of 4-methyl-amphetamine and its isomers 2-methyl-amphetamine and 3-methyl-amphetamine in rat urine using GC-MS and LC-(high-resolution)-MSnJessica Welter, Markus R Meyer, Pierce Kavanagh, et al.
Molecules (Basel, Switzerland)|August 29, 2024
Prevalence of Drugs of Abuse and Cognitive Enhancer Consumption Monitored in Grab Samples and Composite Wastewater via Orbitrap Mass Spectrometry AnalysisFabian Frankenfeld, Lea Wagmann, Cathy M Jacobs, et al.
European Journal of Biochemistry|February 16, 2002
Interaction of the anterior fat body protein with the hexamerin receptor in the blowfly Calliphora vicinaImmo A Hansen, Susanne R Meyer, Ingo Schäfer, et al.
Metabolites|May 26, 2026
Toxicokinetic Studies of the Two Stimulants M-ALPHA and <i>N</i>-Methyl-cyclazodone Using In Vitro and In Vivo ToolsTanja M Gampfer, Samira Klaes, Niels Eckstein, et al.
Journal of Mass Spectrometry : JMS|November 6, 2010
Studies on the metabolism of the α-pyrrolidinophenone designer drug methylenedioxy-pyrovalerone (MDPV) in rat and human urine and human liver microsomes using GC-MS and LC-high-resolution MS and its detectability in urine by GC-MSMarkus R Meyer, Peng Du, Frank Schuster, et al.
Scientific Reports|February 28, 2019
Untargeted metabolomics by high resolution mass spectrometry coupled to normal and reversed phase liquid chromatography as a tool to study the in vitro biotransformation of new psychoactive substancesSascha K Manier, Andreas Keller, Jan Schäper, et al.
Zeitschrift Fur Die Gesamte Innere Medizin Und Ihre Grenzgebiete|August 15, 1989
[Differential assessment of myocardial diseases: hemodynamic-angiocardiography studies and etiologic classification]V Boewer, K Richter, G Schröder, et al.
Dental Materials : Official Publication of the Academy of Dental Materials|March 17, 2004
Determination of polymerization shrinkage stress by means of a photoelastic investigationClaus-Peter Ernst, Gerrit R Meyer, Kerstin Klöcker, et al.
Pageof 221

Showing results (681-690 of 2,204) with videos related to

Sort By:
Pageof 221
Analytica Chimica Acta|April 15, 2014
Methylenedioxy designer drugs: mass spectrometric characterization of their glutathione conjugates by means of liquid chromatography-high-resolution mass spectrometry/mass spectrometry and studies on their glutathionyl transferase inhibition potencyMarkus R Meyer, Lilian H J Richter, Hans H Maurer
IEEE Transactions on Medical Imaging|January 1, 1993
Polynomial modeling and reduction of RF body coil spatial inhomogeneity in MRIM Tincher, C R Meyer, R Gupta, et al.
Analytical and Bioanalytical Chemistry|January 24, 2014
Studies on the metabolism and the detectability of 4-methyl-amphetamine and its isomers 2-methyl-amphetamine and 3-methyl-amphetamine in rat urine using GC-MS and LC-(high-resolution)-MSnJessica Welter, Markus R Meyer, Pierce Kavanagh, et al.
Molecules (Basel, Switzerland)|August 29, 2024
Prevalence of Drugs of Abuse and Cognitive Enhancer Consumption Monitored in Grab Samples and Composite Wastewater via Orbitrap Mass Spectrometry AnalysisFabian Frankenfeld, Lea Wagmann, Cathy M Jacobs, et al.
European Journal of Biochemistry|February 16, 2002
Interaction of the anterior fat body protein with the hexamerin receptor in the blowfly Calliphora vicinaImmo A Hansen, Susanne R Meyer, Ingo Schäfer, et al.
Metabolites|May 26, 2026
Toxicokinetic Studies of the Two Stimulants M-ALPHA and <i>N</i>-Methyl-cyclazodone Using In Vitro and In Vivo ToolsTanja M Gampfer, Samira Klaes, Niels Eckstein, et al.
Journal of Mass Spectrometry : JMS|November 6, 2010
Studies on the metabolism of the α-pyrrolidinophenone designer drug methylenedioxy-pyrovalerone (MDPV) in rat and human urine and human liver microsomes using GC-MS and LC-high-resolution MS and its detectability in urine by GC-MSMarkus R Meyer, Peng Du, Frank Schuster, et al.
Scientific Reports|February 28, 2019
Untargeted metabolomics by high resolution mass spectrometry coupled to normal and reversed phase liquid chromatography as a tool to study the in vitro biotransformation of new psychoactive substancesSascha K Manier, Andreas Keller, Jan Schäper, et al.
Zeitschrift Fur Die Gesamte Innere Medizin Und Ihre Grenzgebiete|August 15, 1989
[Differential assessment of myocardial diseases: hemodynamic-angiocardiography studies and etiologic classification]V Boewer, K Richter, G Schröder, et al.
Dental Materials : Official Publication of the Academy of Dental Materials|March 17, 2004
Determination of polymerization shrinkage stress by means of a photoelastic investigationClaus-Peter Ernst, Gerrit R Meyer, Kerstin Klöcker, et al.
Pageof 221